TGFB1 and Hepatic fibrosis: These results also suggest that disruption of TGF-β1 signal transduction can be considered as one of the critical therapeutic strategy for the treatment of liver fibrosis and prevent advanced liver diseases such as end stage liver cirrhosis and HCC.